Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-22

Clinical Trial Update: Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using synthetic meso tetra (4-carboxyphenyl) porphine (TCPP) for sputum labeling to detect lung cancer; phases 1 and 2 completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TCPP (synthetic meso tetra (4-carboxyphenyl) porphine) (TCPP)

Snippet

Sponsor: Biomoda Inc. | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-22